【财经看点】葛兰素史克中国涉嫌商业贿赂案侦查终结

Chinese police charge British former GSK China head with bribery The Chinese authorities have accused GlaxoSmithKline's former China chief executive of ordering staff to bribe hospital officials to use its products. Chinese police say they have charged Mark Reilly and two Chinese colleagues with corruption, after a probe found the firm made billions of yuan by bribing doctors and hospitals. Former Glaxosmithkline executive Zhao Hongyan is one of the suspects. "Once in Beijing, Mark Reilly, myself and Liang Hong were having dinner, and we briefed Mark Reilly on our relationship building efforts with the Beijing Industry and Commerce Bureau. During dinner, Liang Hong mentioned that costs would be involved when building relations with the Beijing Industry and Commerce Bureau. Mark Reilly's response at that time, in English, was 'Go ahead'." The Chinese authorities announced in July last year that they were investigating GSK, and had detained four Chinese GSK executives. GSK, Britain's biggest drugmaker, said then that it was co-operating with the investigation and that it had zero tolerance for such behaviour.